Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects

Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

(2012) Joseph Tam et al.   Cell Metabolism

A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents

(2010) NL Cluny et al.   BRITISH JOURNAL OF PHARMACOLOGY

The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?

(2010) F.J. Bermudez-Silva et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Guide to Receptors and Channels (GRAC), 3rd edition

(2008) S P H Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats

(2008) R. Nogueiras et al.   DIABETES

Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study †

(2008) Luc F. Van Gaal et al.   EUROPEAN HEART JOURNAL

Extensions to the Visual Predictive Check to facilitate model performance evaluation

(2008) Teun M. Post et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Effect of intrapulmonary tetrahydrocannabinol administration in humans

(2008) L. Zuurman et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625

(2008) L. Zuurman et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Modelling of the concentration—effect relationship of THC on central nervous system parameters and heart rate — insight into its mechanisms of action and a tool for clinical research and development of cannabinoids

(2008) A. Strougo et al.   JOURNAL OF PSYCHOPHARMACOLOGY